Evidence map›Paper›PMID 35175688›Full record

ArticleJournal of thrombosis and haemostasis : JTH2022

Shining a light on platelet activation in COVID-19.

Frederik Denorme, Abigail Ajanel, Robert A Campbell

Abstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Frederik DenormeUniversity of Utah Molecular Medicine Program, Salt Lake City, Utah, USA.ORCID 0000-0003-1442-3568
Abigail AjanelUniversity of Utah Molecular Medicine Program, Salt Lake City, Utah, USA.ORCID 0000-0002-4601-3769
Robert A CampbellUniversity of Utah Molecular Medicine Program, Salt Lake City, Utah, USA.ORCID 0000-0003-0027-694X

Funding

UT StrokeNet Administrative SupplementU24NS107228 · NINDS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jennifer Juhl Majersik · 2018 to 2026
$3.0M
Platelet-Mediated Neutrophil Extracellular Traps Regulate Ischemic Stroke InjuryR01HL163019 · NHLBI · WASHINGTON UNIVERSITY · PI CAMPBELL, ROBERT A · 2022 to 2025
$2.2M
Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in AgingK01AG059892 · NIA · UNIVERSITY OF UTAH · PI CAMPBELL, ROBERT A · 2019 to 2022
$400k
NHLBI NIH HHS R01 HL163019NIA NIH HHS K01 AG059892NIA NIH HHS K01AG059892NINDS NIH HHS U24 NS107228NINDS NIH HHS U24NS107228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansPlatelet ActivationSARS-CoV-2

Identifiers

PMID35175688
PMCPMC9115194

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.